• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Leukaemia Section del(13q) in myeloid malignancies Atlas of Genetics and Cytogenetics
Leukaemia Section del(13q) in myeloid malignancies Atlas of Genetics and Cytogenetics

... Acute non lymphocytic leukemia (ANLL). Epidemiology Structural abnormalities of the RB gene (at 13q14) with absent protein expression is frequent in all types of human acute leukemia but are particularly common (between 20 and 55 % in several studies) in ANLL with monocytic differentiation (M4 and M ...
Implications of Gene Flow and Natural Selection in Genetically
Implications of Gene Flow and Natural Selection in Genetically

Explanations for males with MECP2-related
Explanations for males with MECP2-related

... unrelated events. Because these males have two copies of the X chromosome and undergo the same process of X inactivation that is seen in females, these males present with a clinical presentation that is very consistent with the classic Rett syndrome presentation. These males, will in addition to hav ...
Exploring gene promoters for experimentally
Exploring gene promoters for experimentally

... This application note demonstrates the advantages of TRANSFAC® Professional versus the TRANSFAC® Public release through investigation of the VEGF gene and its binding factors. VEGF gene regulation In this example we’ve chosen to investigate regulatory mechanisms for VEGF (vascular endothelial growth ...
Gene Section FLI1 (Friend leukemia virus integration 1) in Oncology and Haematology
Gene Section FLI1 (Friend leukemia virus integration 1) in Oncology and Haematology

... The fli-1 gene encodes two isoforms of 51 and 48 kDa, synthesized by alternative translation initiation sites, as mentioned above. Loss of function studies have provided evidence to suggest that both the p51 and p48 isoforms retain the same functional domains and activity (Melet et al., 1996). The f ...
Chapter 15
Chapter 15

TreeFam v9: a new website, more species and orthology-on-the
TreeFam v9: a new website, more species and orthology-on-the

... Due to their potentially complex history, the visualization of the evolution of gene families can be a daunting task. Given the 109 species in TreeFam, it can take some time to interpret gene trees of even single copy gene families, let alone families with lots of duplications and losses. To make th ...
Full Lecture 3
Full Lecture 3

... • mutant protein disrupts many pathways within cell eg postsynaptic signaling, regulation of transcription, protein trafficking, vesicle transport over time – combination of effects leads to progressive nerve degeneration? glutamate is known to be neurotoxic, normally cleared by astrocytes relations ...
View PDF - Clinical Journal of Oncology Nursing
View PDF - Clinical Journal of Oncology Nursing

... has an established adverse effect profile (see Table 1). Patients may experience hematologic toxicities, particularly with TMZ, an alkylating agent. In longer-surviving patients, there is a risk of developing a secondary malignancy, such as leukemia or Lisa was 63 years old when she traveled to her ...
Whose got Genes?
Whose got Genes?

... fruits that would result from crossbreeding two plants in his father’s garden Picture taken from biography.com Baker 2003/2004 ...
Genetics PPT
Genetics PPT

... means the first amino acid is Alanine. If the next three nucleic acids are C, C, G, that codes for Proline. Therefore, the ribosome links alanine to proline, and so on, until the entire amino acid sequence is finished.  This new protein is placed in an envelope for protection, and dumped into the e ...
Genetics Practice Test- do and self correct in different color
Genetics Practice Test- do and self correct in different color

Amsterdam 2004 - Theoretical Biology & Bioinformatics
Amsterdam 2004 - Theoretical Biology & Bioinformatics

... rff gene cluster: complex biosynthesis of enterobacteria common antigen (outer membrane). ...
genetics-diseases-for-step-1
genetics-diseases-for-step-1

Genetics Review: What is genetics? Genetics is what makes me
Genetics Review: What is genetics? Genetics is what makes me

... Homozygous: Both alleles of a pair of homologous chromosomes are alike. Heterozygous: Two alleles in a pair of homologous chromosomes are different. Allele: each of several alternative forms of a gene on homologous chromosomes. ○ Lots of alleles are possible in one spot. Phenotype: a manifestation o ...
Muscular Dystrophy
Muscular Dystrophy

... • The diagnosis of muscular dystrophy is based on the results of a muscle biopsy and increased creatine phosphokinase (CpK3). In some cases, a DNA blood test may be all that is needed. • Progressive muscular wasting, poor balance, drooping eyelids, gonadal, loss of bladder are just some of the many ...
11_Lecture_Presentation
11_Lecture_Presentation

... information flow from genes to proteins – Mainly controlled at the level of transcription – A gene that is “turned on” is being transcribed to produce mRNA that is translated to make its corresponding protein – Organisms respond to environmental changes by controlling gene expression ...
1 - western undergrad. by the students, for the students.
1 - western undergrad. by the students, for the students.

... iii) recombination events can occur anywhere along the DNA molecule iv) resolution of Holliday junctions in different planes result in crossing over v) branch migration can result in the creation of heteroduplex regions no greater than 2.5 ...
Gene Section TRPM1 (transient receptor potential cation channel, subfamily M, member 1)
Gene Section TRPM1 (transient receptor potential cation channel, subfamily M, member 1)

... directly and suppress the activity of full length form of TRPM1 (MLSN1-L), preventing its translocation to the plasma membrane (Xu et al., 2001), representing a mode of regulation of the channel activities. Presence of multiple isoforms of TRPM1 in normal melanocytes as well as pigment cell melanoma ...
Gene Section WFDC1 (WAP four-disulfide core domain 1) in Oncology and Haematology
Gene Section WFDC1 (WAP four-disulfide core domain 1) in Oncology and Haematology

... Nov;32(3):355-7 Saffroy R, Riou P, Soler G, Azoulay D, Emile JF, Debuire B, Lemoine A. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma. Eur J Hum Genet. 2002 Apr;10(4):239-44 ...
ZNF232: structure and expression analysis of a novel human C2H2
ZNF232: structure and expression analysis of a novel human C2H2

... the amino terminal, where a ¢nger associated motif, the Khelical leucine-rich SCAN/LeR domain [12,13] is recognized (aa 49^130), and the carboxy terminal zinc ¢nger region, characterized by ¢ve consecutive repeats of the C2 H2 type (aa 278^410). A putative nucleus localization signal (NLS; aa sequen ...
What is a Designer Baby?
What is a Designer Baby?

... term used by journalists, not scientists. A more realistic term would be “Selected Baby”. It is currently not attainable to insert genes into embryos in hopes of desired characteristic traits or physical features, however advanced technologies can be used to select the sex of your future offspring a ...
Document
Document

... The requirement to standardise treatments means trials use manualised treatments. These have limited applicability to everyday practice. ...
Week 8 - GEA
Week 8 - GEA

... Department of Genetics, Cell Biology and Anatomy University of Nebraska Medical Center ...
CGC07OthrGene - Cucurbit Breeding
CGC07OthrGene - Cucurbit Breeding

... cucumber, melon and watermelon. Those are major crop species originally from the Old World: cucumber from India; melon and watermelon from Africa (Wehner and Maynard, 2003). However, there are other important species originally from Africa such as gherkin (Cucumis anguria), African horned melon (Cuc ...
< 1 ... 319 320 321 322 323 324 325 326 327 ... 556 >

Gene therapy



Gene therapy is the therapeutic delivery of nucleic acid polymers into a patient's cells as a drug to treat disease. Gene therapy could be a way to fix a genetic problem at its source. The polymers are either expressed as proteins, interfere with protein expression, or possibly correct genetic mutations.The most common form uses DNA that encodes a functional, therapeutic gene to replace a mutated gene. The polymer molecule is packaged within a ""vector"", which carries the molecule inside cells.Gene therapy was conceptualized in 1972, by authors who urged caution before commencing human gene therapy studies. By the late 1980s the technology had already been extensively used on animals, and the first genetic modification of a living human occurred on a trial basis in May 1989 , and the first gene therapy experiment approved by the US Food and Drug Administration (FDA) occurred on September 14, 1990, when Ashanti DeSilva was treated for ADA-SCID. By January 2014, some 2,000 clinical trials had been conducted or approved.Early clinical failures led to dismissals of gene therapy. Clinical successes since 2006 regained researchers' attention, although as of 2014, it was still largely an experimental technique. These include treatment of retinal disease Leber's congenital amaurosis, X-linked SCID, ADA-SCID, adrenoleukodystrophy, chronic lymphocytic leukemia (CLL), acute lymphocytic leukemia (ALL), multiple myeloma, haemophilia and Parkinson's disease. Between 2013 and April 2014, US companies invested over $600 million in the field.The first commercial gene therapy, Gendicine, was approved in China in 2003 for the treatment of certain cancers. In 2011 Neovasculgen was registered in Russia as the first-in-class gene-therapy drug for treatment of peripheral artery disease, including critical limb ischemia.In 2012 Glybera, a treatment for a rare inherited disorder, became the first treatment to be approved for clinical use in either Europe or the United States after its endorsement by the European Commission.
  • studyres.com © 2026
  • DMCA
  • Privacy
  • Terms
  • Report